<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:04:20Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12794" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12794</identifier><datestamp>2026-10-18T20:36:45Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Cytotoxic and Apoptotic Effects of Carmofur and Vitamin C Combination on HCT116 Colon Cancer Cells</dc:title><dc:creator>Danışman-Kalındemirtaş, Ferdane</dc:creator><dc:subject>Carmofur</dc:subject><dc:subject>colon cancer</dc:subject><dc:subject>combined therapy</dc:subject><dc:subject>HCT116</dc:subject><dc:subject>vitamin C</dc:subject><dc:description>Objective: In recent years, especially combined treatment options that will reduce the side effects of drugs have attracted attention. Carmofur is a new potent agent being investigated in the treatment of cancer. This study aimed to investigate the cytotoxic and apoptotic effects of carmofur+vitamin C combination in colon cancer cells. Materials and Methods: Carmofur in the range of 7.8-250 µM, vitamin C in 7.8 µM-2mM and carmofur+vitamin C in different concentrations were evaluated on HCT116 cells by MTT test. In addition, the cell death pathway was determined by an apoptosis-necrosis assay. Results: The IC50 value of carmofur in HCT116 cells was 8 µM, vitamin C was not effective at low doses, and the IC50 value was 2.2 mM. When carmofur+vitamin C were applied to HCT116 cells, 4 µM carmofur and 125 µM vitamin C together inhibited half of the cells (IC50), while 4 µM carmofur and 2 mM vitamin C inhibited half of the cells similarly. Conclusion: Vitamin C doubled the anticancer effect of carmofur. As a result, it was observed that vitamin C supplementation significantly increased cell death in anticancer drug administration. In addition, it was determined that the addition of vitamin C significantly increased the apoptotic activity. © 2022, Istanbul University Press. All rights reserved.</dc:description><dc:publisher>Istanbul University Press</dc:publisher><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/12794</dc:identifier><dc:identifier>https://doi.org/10.26650/experimed.2021.1038579</dc:identifier><dc:identifier>2667-5846</dc:identifier><dc:language>en</dc:language><dc:relation>Experimed</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/12794</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>